|
|
|
|
|
16.12.25 - 22:06
|
Illumina To Webcast Upcoming Investor Conference (PR Newswire)
|
|
|
SAN DIEGO, Dec. 16, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 The presentation......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.11.25 - 22:09
|
Illumina To Webcast Upcoming Investor Conference (PR Newswire)
|
|
|
SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Wolfe Research Healthcare Conference 2025 on November 19, 2025 Fireside chat at 6:20am Pacific Time (9:20am Eastern Time) The......
|
|
|
|
|
10.11.25 - 14:06
|
Iambic Raises Over $100 Million in an Oversubscribed Round to Advance Its Portfolio of AI-Discovered Therapeutics and Leading Platform Technologies (Business Wire)
|
|
|
Support comes from new and existing investors, including life science, technology, growth, and sovereign wealth investors
Financing closely follows announcements of Iambic's clinical data for IAM1363 at the ESMO Congress and entry into a clinical collaboration with Jazz Pharmaceuticals
SAN DIEGO--(BUSINESS WIRE)--Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced raising over $100 million in an oversubscribed financing round with balanced support from new and existing investors, including Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Mubadala, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsini Goodrich & Rosati, and others.
"We are thrilled to have the support of many outstanding and committed investors...
|
|
|
|
|
|
|
|
|
05.11.25 - 20:06
|
Illumina and Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights (Business Wire)
|
|
|
The company's transformer model interprets up to one billion DNA fragments in each blood sample, capturing molecular context at a scale hundreds of times greater than leading LLMs and demonstrating strong clinical validation
With $6.7 million seed led by Felicis Ventures and Illumina Ventures, Hepta advances liquid biopsy platforms beyond oncology
FOSTER CITY, Calif.--(BUSINESS WIRE)--Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today emerged from stealth with $6.7 million in seed funding led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures. The company also revealed clinical data showing its AI-powered epigenetics platform can identify patients with metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) with significant fibrosis with a diagnostic AUC of 0.86, cutting false positives threefold compa...
|
|
|
02.11.25 - 16:48
|
Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? (Benzinga)
|
|
|
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results.
read more...
|
|
|
|
|
31.10.25 - 19:13
|
′Hopeful′ We′ll Find Long-term Solution On China: Illumina CEO (Bloomberg)
|
|
|
Illumina reported revenue growth and raised its financial guidance for the second straight quarter. Illumina CEO Jacob Thaysen acknowledged the ongoing challenges from US–China export restrictions but said Illumina remains committed to the market while maintaining strong performance globally. He discussed the outlook on "Bloomberg Markets" with Scarlet Fu and Bloomberg The Close's co-anchor Katie Greifeld. (Source: Bloomberg)...
|
|